Data for (Study ST001223)
(Analysis AN002036)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 | F3 | F4 |
|---|---|---|---|---|
| 12-oxo-LTB4 | 2.1624 | 0.8660 | 0.0272 | 0.0255 |
| Arachidonic acid | 1.4052 | 1.4585 | 0.1753 | 0.2811 |
| Decanoylcarnitine | 1.2235 | 0.6539 | 0.3923 | 1.3370 |
| glycochenodeoxycholic acid | 1.5350 | 0.8705 | 0.3346 | 0.7126 |
| glycocholic acid | 1.6809 | 0.6956 | 0.3507 | 0.7144 |
| glycodeoxycholic acid | 1.4113 | 0.9092 | 0.4394 | 0.7884 |
| glycolithocholic acid | 1.1489 | 0.9793 | 0.4893 | 1.0297 |
| glycoursodeoxycholic acid | 1.2261 | 0.9077 | 0.4765 | 1.0153 |
| HETE | 1.9055 | 1.1459 | 0.0225 | 0.0450 |
| Hexanoylcarnitine | 1.0810 | 0.6179 | 0.4872 | 1.5249 |
| L-acetylcarnitine | 1.1671 | 0.7033 | 0.5032 | 1.3112 |
| L-octanoylcarnitine | 1.1514 | 0.5777 | 0.4162 | 1.5066 |
| Lyso-PAF C18 | 1.6063 | 1.1160 | 0.2891 | 0.3618 |
| LysoPC (16:0) | 1.2829 | 0.9246 | 0.4338 | 0.9394 |
| LysoPC (16:0) -2 | 1.2793 | 0.9521 | 0.4401 | 0.9106 |
| LysoPC (18:0) | 1.3448 | 0.9647 | 0.4005 | 0.8272 |
| LysoPC (18:0) -2 | 1.3486 | 1.0092 | 0.3622 | 0.7871 |
| LysoPC (20:0) | 1.3873 | 1.0940 | 0.3518 | 0.6456 |
| LysoPC (20:0) -2 | 1.3778 | 1.1128 | 0.3771 | 0.6269 |
| PGB2 | 1.5949 | 1.4365 | 0.0735 | 0.1002 |
| Propionylcarnitine | 1.1468 | 0.6855 | 0.5267 | 1.3482 |
| PUFA | 1.9969 | 1.0783 | 0.0058 | 0.0093 |
| SM (d18:1/16:0) | 1.3553 | 1.0182 | 0.4244 | 0.7440 |
| Sphingosine (d16:0) | 1.4709 | 0.9092 | 0.4431 | 0.7097 |
| taurochenodeoxycholic acid | 1.5461 | 0.7183 | 0.3807 | 0.8515 |
| taurodeoxycholic acid | 1.5247 | 0.7594 | 0.3809 | 0.8329 |
Factors:
| F1 | Sample Type:Early Disseminated Lyme |
| F2 | Sample Type:Early Localized Lyme |
| F3 | Sample Type:Healthy Non-endemic control |
| F4 | Sample Type:Heatlhy Controls - Endemic |
